Stable Istotope Labelled Tilavonemab Biosimilar – Anti-MAPT mAb – Research Grade
| Size | |
|---|---|
| Brand | |
| Product type | |
| Clonality | |
| Expression system | |
| Applications |
| Product name | Stable Istotope Labelled Tilavonemab Biosimilar - Anti-MAPT mAb - Research Grade |
|---|---|
| Source | CAS 2096513-89-0 |
| Species | Chimeric |
| Expression system | Mammalian cells |
| Purity | >95% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue Ice |
| Delivery Time | 3-5 days if in stock; 5-8 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | ABBV-8E12, C2N-8E12 |
| Reference | PX-TA1404-SIL |
| Related Products | PX-P4405 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG4-kappa |
| Clonality | Monoclonal Antibody |
| Format | Lyophilized |
| Labelling | Arginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99% |
| Isotopic Enrichment | 99% |
| Stability | 1 year |
General information on Anti-MAPT[Homo sapiens] (Tilavonemab ) Monoclonal Antibody
Tilavonemab has been investigated for the treatment of Alzheimer’s disease.
Contact us
Send us a message from the form below
Reviews
There are no reviews yet.